The Index tracks the price movements in shares of companies which are active in the field of Genomics. These companies include those involved in the following business activities: gene editing, genomic sequencing, development and testing of genetic medicine or therapies, computational genomics and genetic diagnostics or biotechnology. Companies are only eligible if they generate at least 50% of their revenues from Genomics related business operations and/or are classified as “Biotechnology” according to the FactSet Industries and Economic Sectors classification system. To be eligible, a company must have it's primary listing in a developed market. Additionally, ADRs of any company whose primary listing is in a country that is part of the emerging markets are eligible. The top 40 companies are included in the Index.
0.00
As of 06/26/2022
2022 © Stock Market MBA, Inc.